Motixafortide (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ~1 nM.
CAT No: HB00088
CAS No:664334-36-5
Synonyms/Alias:Motixafortide;BKT140;664334-36-5;BKT140 acetate salt;Motixafortide (BL-8040);GLXC-20012;s9665;AKOS032944983;AS-84209;DA-61745;F85502;Bz(4-F)-Arg-Arg-2Nal-Cys(1)-Tyr-Cit-Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys(1)-Arg-NH2;N2-(4-Fluorobenzoyl)-Arg-Arg-Nal-Cys-Tyr-Cit-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.